↑↓ navigate ↵ open esc close
SELL TO STATE.
Start free trial
Czech Republic NEN contract award · ocds-ted-5312-2026

Czechia – Antineoplastic and immunomodulating agents – Dodávky léků – Filgotinib 2025 (JYSELECA)

Revmatologický ústav awarded Kč40.1M to PHARMOS, a.s. for Professional Services & Consulting in January 2026 — one of 49 awards this buyer has made, above its typical award size.

Professional Services & Consulting
06 Jan 2026
Award date
Kč40.1M
Contract value

Buying agency

Revmatologický ústav
49 Awards
Kč32.0M Avg award
Above vs typical

Winning supplier

PHARMOS, a.s.
594 Awards
35 Buyers
Kč2.7B Total won

Contract description

Czechia – Antineoplastic and immunomodulating agents – Dodávky léků – Filgotinib 2025 (JYSELECA)

Premium

Related awards · Revmatologický ústav

49 awards

The buyer's full award list ranked by value, with the winning supplier, date and sector on every row — plus CSV / API export.

Tender no.SupplierAmountDateSector

Full dataset

Unlock the full data.

Subscribe to reveal every row, year-over-year trends, and CSV / API export.

Unlock full dataset →

5 more awards from this buyer · full history & CSV export

Premium

Other wins · PHARMOS, a.s.

594 wins

The supplier's complete win history across every buyer it sells to — not just the handful shown here.

Tender no.BuyerAmountDateSector
Locked rows — unlock the full dataset below.

Premium · full dataset

See the full award context.

Competing bids, award margins and every related contract for Revmatologický ústav and PHARMOS, a.s. — one subscription unlocks everything.

Sign Up Free →

Free account · cancel anytime · 14-day money-back

Sign Up